Some targets, such as CLDN6 (169), EZH2 (170), mesothelin (171), TRPV6 (172), GDF15 (173), SHP2 (174), DLL3 (175), and alpha-folate receptor (176, 177) were overexpressed in ovarian cancer or associated with unfavorable prognosis. This evidence concerns the gene MSLN and ovarian carcinoma.